These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34087280)

  • 41. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Approaches to Targeting Cancer Stem Cells in Solid Tumors.
    Caldas-Lopes E; Gomez-Arteaga A; Guzman ML
    Curr Stem Cell Res Ther; 2019; 14(5):421-427. PubMed ID: 30806324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cancer stem cells - A therapeutic target?
    Maitland NJ; Collins AT
    Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancer Stem Cells: Root of the Evil.
    Erkisa M; Karakas D; Ulukaya E
    Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.
    Zhang L; Tong X; Li J; Huang Y; Hu X; Chen Y; Huang J; Wang J; Liu B
    Cell Prolif; 2015 Aug; 48(4):385-97. PubMed ID: 26013704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanomedicine strategies for sustained, controlled and targeted treatment of cancer stem cells.
    Gao J; Li W; Guo Y; Feng SS
    Nanomedicine (Lond); 2016 Dec; 11(24):3261-3282. PubMed ID: 27854161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quinacrine Based Gold Hybrid Nanoparticles Caused Apoptosis through Modulating Replication Fork in Oral Cancer Stem Cells.
    Hembram KC; Dash SR; Das B; Sethy C; Chatterjee S; Bindhani BK; Kundu CN
    Mol Pharm; 2020 Jul; 17(7):2463-2472. PubMed ID: 32407635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural Products Inspired Modulators of Cancer Stem Cells-specific Signaling Pathways Notch and Hedgehog.
    Palermo R; Ghirga F; Piccioni MG; Bernardi F; Zhdanovskaya N; Infante P; Mori M
    Curr Pharm Des; 2018; 24(36):4251-4269. PubMed ID: 30636589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting cancer stem cells by using the nanoparticles.
    Hong IS; Jang GB; Lee HY; Nam JS
    Int J Nanomedicine; 2015; 10(Spec Iss):251-60. PubMed ID: 26425092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting Cancer Stem Cells to Overcome Chemoresistance.
    Nunes T; Hamdan D; Leboeuf C; El Bouchtaoui M; Gapihan G; Nguyen TT; Meles S; Angeli E; Ratajczak P; Lu H; Di Benedetto M; Bousquet G; Janin A
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30551640
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
    Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
    J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

  • 56. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
    Maiuthed A; Chantarawong W; Chanvorachote P
    Anticancer Res; 2018 Jul; 38(7):3797-3809. PubMed ID: 29970499
    [TBL] [Abstract][Full Text] [Related]  

  • 58. At the crossroads of cancer stem cells and targeted therapy resistance.
    Wang A; Qu L; Wang L
    Cancer Lett; 2017 Jan; 385():87-96. PubMed ID: 27816488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
    Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
    Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical and therapeutic implications of cancer stem cell biology.
    Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.